Fuentivilla, Jermie Gil .

HRN: 26-50-05  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/07/2025
CEFUROXIME 750MG (VIAL)
01/07/2025
01/14/2025
IV
750 Mg
Q8h
Uti
Waiting Final Action 
01/09/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/09/2025
01/16/2025
IV
400mg
Q8
S/p Exlap Ap
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: